ReSViNET | Respiratory Syncytial Virus (RSV) Foundation

📢 𝐉𝐨𝐢𝐧 𝐮𝐬 𝐟𝐨𝐫 𝐭𝐡𝐞 𝐧𝐞𝐱𝐭 𝐖𝐇𝐎 𝐑𝐒𝐕 𝐑𝐨𝐚𝐝𝐬𝐡𝐨𝐰 𝐖𝐞𝐛 𝐄𝐯𝐞𝐧𝐭: 𝐑𝐒𝐕 𝐈𝐦𝐦𝐮𝐧𝐢𝐬𝐚𝐭𝐢𝐨𝐧 – 𝐏𝐢𝐩𝐞𝐥𝐢𝐧𝐞 𝐭𝐨 𝐆𝐥𝐨𝐛𝐚𝐥 𝐏𝐨𝐥𝐢𝐜𝐲 𝐚𝐧𝐝 𝐏𝐫𝐨𝐠𝐫𝐚𝐦𝐦𝐚𝐭𝐢𝐜 𝐔𝐬𝐞! What are the pathways to RSV prevention access and use in low- and middle-income markets? We will discuss policy consideration on the pathway to global RSV prevention for infants and young children, including vaccine introduction timeline drivers; global policy and WHO prequalification processes; immunization financing; and country policymaking. We will also discuss new RSV immunization product implementation considerations and adaptations that may be needed to introduce and scale up delivery. 📅 Date: Wednesday, 15 January 2025 🕒 Time: 15:00 – 16:00 CET 🎯 Topic: The RSV Immunisation Pipeline to Global Policy and Programmatic Use 👉 Register now! https://lnkd.in/gfQmZ6qu (if you have registered for the previous WHO RSV Roadshows, you will receive a direct TEAMS link) #RSV #GlobalHealth #InfantHealth #RSVPrevention #WHOWebinars

𝐑𝐞𝐒𝐕𝐢𝐍𝐄𝐓 𝐏𝐚𝐩𝐞𝐫 𝐨𝐟 𝐭𝐡𝐞 𝐌𝐨𝐧𝐭𝐡 - 𝐍𝐨𝐯𝐞𝐦𝐛𝐞𝐫 𝟐𝟎𝟐𝟒 𝐅𝐮𝐥𝐥 𝟐𝟎𝟐𝟑–𝟐𝟒 𝐬𝐞𝐚𝐬𝐨𝐧 𝐫𝐞𝐬𝐮𝐥𝐭𝐬 𝐨𝐟 𝐮𝐧𝐢𝐯𝐞𝐫𝐬𝐚𝐥 𝐩𝐫𝐨𝐩𝐡𝐲𝐥𝐚𝐱𝐢𝐬 𝐰𝐢𝐭𝐡 𝐧𝐢𝐫𝐬𝐞𝐯𝐢𝐦𝐚𝐛 𝐢𝐧 𝐆𝐚𝐥𝐢𝐜𝐢𝐚, 𝐒𝐩𝐚𝐢𝐧: 𝐭𝐡𝐞 𝐍𝐈𝐑𝐒𝐄-𝐆𝐀𝐋 𝐬𝐭𝐮𝐝𝐲 Every month the ReSViNET board select a paper of the month related to RSV (Respiratory Syncytial Virus). This paper describes the results of the NIRSE-GAL study in Spain. 📌 Read full publication here: https://lnkd.in/egYMK6Ks #RSV #Publications #ReSViNET #Nirsevimab

As a follow-up to the panel discussion at the World Vaccine Congress (WVC), a new article  "Health systems need to use the new tools to address RSV, a leading cause of baby hospitalisations" has been published in Health Policy Watch. The article explores significant advancements in the prevention of Respiratory Syncytial Virus (#RSV), a leading cause of infant hospitalizations globally. It highlights the impact of new solutions, such as long-acting monoclonal antibodies (mAbs) and maternal vaccination, both recently recommended by the World Health Organization (WHO). Real-world examples from Spain and Italy demonstrate the effectiveness of immunization campaigns in reducing RSV-related hospitalizations. If you're interested in learning more about how these innovations are shaping the future of infant health, read the full article: https://lnkd.in/euDxVauR Leyla Kragten-Tabatabaie Susan Hepworth #RSV #InfantHealth #Vaccines #HealthPolicy #WVC #HealthcareInnovation #HealthSystems

📢 𝐉𝐨𝐢𝐧 𝐮𝐬 𝐟𝐨𝐫 𝐭𝐡𝐞 𝐧𝐞𝐱𝐭 𝐖𝐇𝐎 𝐑𝐒𝐕 𝐑𝐨𝐚𝐝𝐬𝐡𝐨𝐰 𝐖𝐞𝐛 𝐄𝐯𝐞𝐧𝐭 𝐨𝐧 𝐭𝐡𝐞 𝐄𝐜𝐨𝐧𝐨𝐦𝐢𝐜𝐬 𝐨𝐟 𝐑𝐒𝐕 𝐏𝐫𝐞𝐯𝐞𝐧𝐭𝐢𝐨𝐧! What are the cost implications of RSV prevention? Join us for an overview and discussion of the latest estimates around the costs, cost-effectiveness, and public health impact of RSV maternal vaccines and monoclonal antibodies for low- and middle-income markets. 📅 Date: Wednesday, 4 December 2024 🕒 Time: 15:00 – 16:00 CET 🎯 Topic: The Economics of RSV Prevention 👉 Register now! https://lnkd.in/gfQmZ6qu (if you have registered for the previous WHO RSV Roadshows, you will receive a direct TEAMS link) #RSV #GlobalHealth #InfantHealth #RSVPrevention #WHOWebinars

📢 𝐉𝐨𝐢𝐧 𝐮𝐬 𝐟𝐨𝐫 𝐭𝐡𝐞 𝐧𝐞𝐱𝐭 𝐖𝐇𝐎 𝐑𝐒𝐕 𝐑𝐨𝐚𝐝𝐬𝐡𝐨𝐰 𝐖𝐞𝐛 𝐄𝐯𝐞𝐧𝐭 𝐨𝐧 𝐭𝐡𝐞 𝐄𝐜𝐨𝐧𝐨𝐦𝐢𝐜𝐬 𝐨𝐟 𝐑𝐒𝐕 𝐏𝐫𝐞𝐯𝐞𝐧𝐭𝐢𝐨𝐧! What are the cost implications of RSV prevention? Join us for an overview and discussion of the latest estimates around the cost, cost-effectiveness, and public health impact of RSV maternal vaccines and monoclonal antibodies for low- and middle-income markets. 📅 Date: Wednesday, 4 December 2024 🕒 Time: 15:00 – 16:00 CET 🎯 Topic: The Economics of RSV Prevention 👉 Register now! https://lnkd.in/gfQmZ6qu (if you have registered for the previous WHO RSV Roadshows, you will receive a direct TEAMS link) #RSV #GlobalHealth #InfantHealth #RSVPrevention #WHOWebinars

🌍𝐖𝐨𝐫𝐥𝐝 𝐏𝐧𝐞𝐮𝐦𝐨𝐧𝐢𝐚 𝐃𝐚𝐲 and 𝐎𝐮𝐫 𝐑𝐒𝐕 𝐂𝐡𝐚𝐭𝐛𝐨𝐭 𝐢𝐬 𝐋𝐈𝐕𝐄! Yesterday, ReSViNET and UMC Utrecht came together at the Wilhelmina Kinderziekenhuis (Het WKZ), part of the UMC Utrecht , to mark World Pneumonia Day (November 12th). The entire building was illuminated in blue in recognition of this day, joining a global movement to raise awareness of pneumonia. RSV is one of the leading causes of pneumonia in both young children and older adults. In young children, RSV can quickly progress to pneumonia, often requiring hospitalization. For older adults, particularly those with chronic health conditions, RSV-related pneumonia presents significant risks. To further support this mission, we are thrilled to launch our new RSV Chatbot - a digital tool designed to provide accessible and reliable information about Respiratory Syncytial Virus (RSV) for everyone, including parents and caregivers. Our RSV Chatbot is available 24/7 in nearly all languages through the ReSViNET website and on WhatsApp. Created alongside experts from UMC Utrecht, it’s designed to answer your questions on RSV symptoms, prevention, and caregiving support. TRY OUT RSV CHATBOT NOW: https://lnkd.in/eK3hcUNv #RSV #ReSViNET #WorldPneumoniaDay #RSVChatbot Every Breath Counts Coalition

🌍𝐓𝐨𝐝𝐚𝐲 𝐢𝐬 𝐖𝐨𝐫𝐥𝐝 𝐏𝐧𝐞𝐮𝐦𝐨𝐧𝐢𝐚 𝐃𝐚𝐲 and 𝐎𝐮𝐫 𝐑𝐒𝐕 𝐂𝐡𝐚𝐭𝐛𝐨𝐭 𝐢𝐬 𝐋𝐈𝐕𝐄! We’re excited to mark the occasion by launching our brand-new RSV Chatbot - a powerful digital tool that provides accessible, reliable information about Respiratory Syncytial Virus (RSV) for everyone, including parents and caregivers. Why focus on RSV today? RSV is one of the leading causes of pneumonia in infants and older adults. In young children, RSV can quickly progress to pneumonia, often requiring hospitalization. And for older adults, especially those with chronic health conditions, RSV-related pneumonia poses significant risks. Our RSV Chatbot is available 24/7 in nearly all languages through the ReSViNET website and on WhatsApp. Created alongside experts from UMC Utrecht, it’s designed to answer your questions on RSV symptoms, prevention, and caregiving support. We believe this tool will be a game-changer in raising awareness and providing quick, accurate RSV information to those who need it most. This launch is a big step forward in making critical health information more accessible, bridging research and real-world application. Visit our website today to learn more about this valuable resource and be one of the first to try it out! Let’s work together to spread RSV knowledge, support caregivers, and make a difference in the fight against pneumonia. Go to: https://lnkd.in/eK3hcUNv Every Breath Counts Coalition #RSV #ReSViNET #WorldPneumoniaDay #RSVChatbot

📢 𝐋𝐚𝐮𝐧𝐜𝐡𝐢𝐧𝐠 𝐑𝐞𝐒𝐕𝐢𝐍𝐄𝐓'𝐬 𝐑𝐒𝐕 𝐂𝐡𝐚𝐭𝐛𝐨𝐭 𝐨𝐧 𝐖𝐨𝐫𝐥𝐝 𝐏𝐧𝐞𝐮𝐦𝐨𝐧𝐢𝐚 𝐃𝐚𝐲, 𝐍𝐨𝐯𝐞𝐦𝐛𝐞𝐫 𝟏𝟐! At ReSViNET, we’re dedicated to reduce the global burden of RSV infection. RSV is one of the leading causes of pneumonia in young children and older adults. In honor of World Pneumonia Day 2024, we’re excited to introduce an innovative tool: the RSV chatbot. Created by the ReSViNET Foundation in collaboration with UMC Utrecht researchers. This 24/7 chatbot offers reliable, expert-verified information on RSV in almost every language. Access it anytime on the ReSViNET website or via WhatsApp. The launch of the RSV chatbot is a powerful step toward making essential RSV information accessible to families and patients everywhere, helping translate research into practical support. Go to our website: resvinet.org/chatbot Every Breath Counts Coalition #RSV #ReSViNET #WorldPneumoniaDay #RSVChatbot

Our attendance of the ICM conference would not be complete without our own ReSViNET poster! Many thanks to all the writers who supported this study and poster! ⁦‪International Confederation of Midwives (ICM) #midwife #midwifery #rsv #research

📢 𝐋𝐚𝐮𝐧𝐜𝐡𝐢𝐧𝐠 𝐑𝐞𝐒𝐕𝐢𝐍𝐄𝐓'𝐬 𝐑𝐒𝐕 𝐂𝐡𝐚𝐭𝐛𝐨𝐭 𝐨𝐧 𝐖𝐨𝐫𝐥𝐝 𝐏𝐧𝐞𝐮𝐦𝐨𝐧𝐢𝐚 𝐃𝐚𝐲, 𝐍𝐨𝐯𝐞𝐦𝐛𝐞𝐫 𝟏𝟐! We are thrilled to announce the official launch of our RSV Chatbot, a new digital tool dedicated to providing general public including parents and caregivers reliable, round-the-clock information on Respiratory Syncytial Virus (RSV). On World Pneumonia Day, RSV is highlighted specifically because it’s one of the leading causes of pneumonia in young children and older adults. For infants, RSV can rapidly progress to pneumonia, often requiring hospitalization. Older adults, particularly those with chronic conditions, face a high risk of complications from RSV-related pneumonia, leading to serious health outcomes. The RSV Chatbot, available on our website and WhatsApp, will help answer questions about RSV symptoms, prevention methods, and care advice. With integrated video content and article references, the chatbot offers deepened insights to users seeking detailed guidance and knowledge. The chatbot is created in collaboration with RSV experts from the UMC Utrecht. We are confident that this tool will be a vital resource in promoting RSV awareness and health education, delivering timely support to those who need it most. This launch represents a major step in our commitment to empowering caregivers and patients with critical RSV information, bridging the gap between research and real-world application. Please join us on November 12 to mark this milestone as we introduce the RSV Chatbot to the world. For all the details and exclusive access to our RSV Chatbot, visit our website and be among the first to experience this exciting new tool! Let’s unite to raise awareness, prevent pneumonia, and support RSV education worldwide. #RSV #ReSViNET #WorldPneumoniaDay #RSVChatbot Every Breath Counts Coalition